BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2994198)

  • 1. Epidemiology of cytomegaloviral infections: recommendations for prevention and control.
    Onorato IM; Morens DM; Martone WJ; Stansfield SK
    Rev Infect Dis; 1985; 7(4):479-97. PubMed ID: 2994198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-associated cytomegalovirus infections.
    Adler SP
    Rev Infect Dis; 1983; 5(6):977-93. PubMed ID: 6318291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Washing our hands of the congenital cytomegalovirus disease epidemic.
    Cannon MJ; Davis KF
    BMC Public Health; 2005 Jun; 5():70. PubMed ID: 15967030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study.
    Preiksaitis JK; Desai S; Vaudry W; Roberts S; Akabutu J; Grundy P; Wilson B; Boshkov L; Hannon J; Joffres M
    Transfusion; 1997 Sep; 37(9):941-6. PubMed ID: 9308642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and consequences of cytomegalovirus transmission via blood transfusion to low birth weight, premature infants in north east Scotland.
    Galea G; Urbaniak SJ
    Vox Sang; 1992; 62(4):200-7. PubMed ID: 1322610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal acquired cytomegalovirus infection in a neonate with maternal antibody.
    de Cates CR; Roberton NR; Walker JR
    J Infect; 1988 Nov; 17(3):235-9. PubMed ID: 2851021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus: epidemiology and infection control.
    Pomeroy C; Englund JA
    Am J Infect Control; 1987 Jun; 15(3):107-19. PubMed ID: 3039875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatally acquired cytomegalovirus infections in infants of CMV-excreting mothers.
    Kumar ML; Nankervis GA; Cooper AR; Gold E
    J Pediatr; 1984 May; 104(5):669-73. PubMed ID: 6325653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus.
    Adler SP; Lawrence LT; Baggett J; Biro V; Sharp DE
    Transfusion; 1984; 24(4):333-5. PubMed ID: 6087517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
    Bowden RA; Slichter SJ; Sayers M; Weisdorf D; Cays M; Schoch G; Banaji M; Haake R; Welk K; Fisher L; McCullough J; Miller W
    Blood; 1995 Nov; 86(9):3598-603. PubMed ID: 7579469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of cytomegalovirus in the Gambia.
    Bello CS
    West Afr J Med; 1992; 11(2):140-5. PubMed ID: 1327087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of acquired cytomegalovirus infection among children in group day care.
    Murph JR; Bale JF
    Am J Dis Child; 1988 Aug; 142(8):843-6. PubMed ID: 2839977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased rate of cytomegalovirus infection among parents of children attending day-care centers.
    Pass RF; Hutto C; Ricks R; Cloud GA
    N Engl J Med; 1986 May; 314(22):1414-8. PubMed ID: 3010113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of cytomegalovirus infection among children between the ages of 4 and 12 years in Taiwan.
    Shen CY; Chang WW; Chang SF; Chao MF; Huang ES; Wu CW
    J Med Virol; 1992 May; 37(1):72-5. PubMed ID: 1320100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method of blood processing affects the prevalence of cytomegalovirus excretion in newborn nurseries.
    Brady MT; Demmler GJ; Seavy D; Reis S
    Am J Infect Control; 1987 Dec; 15(6):245-8. PubMed ID: 2830809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast milk transmission of cytomegalovirus (CMV) infection.
    Alford C
    Adv Exp Med Biol; 1991; 310():293-9. PubMed ID: 1667068
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
    Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of cytomegalovirus infection: an update.
    Forbes BA
    Clin Microbiol Rev; 1989 Apr; 2(2):204-16. PubMed ID: 2539899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
    Preiksaitis JK; Sandhu J; Strautman M
    Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection. Overview and new developments.
    Bhumbra NA; Nankervis GA
    Postgrad Med; 1983 Apr; 73(4):62-9. PubMed ID: 6300818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.